Nov 11, 2022
1:20
For every 20 shares held, investors received 1.
The split itself did not change the total investment value.
Rein Therapeutics Inc. (RNTX) trades on the NASDAQ Global Market in the Biotechnology industry.
Rein Therapeutics Inc. company overviewThe latest split shown was on November 11, 2022. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records one reverse split, on November 11, 2022.